Patent · US Active

Single domain antibodies against SOD1 and their use in medicine

US9862777B2 · kind B2 · utility

4Cited by

0References

15Claims

0Family size

Assignees

VIB VZW · BE
Life Sciences Research Partners VZW · BE
Katholieke Universiteit Leuven, KU LEUVEN R&D · BE

Inventors

Wim Robberecht · Kumtich, BE
Frederic Rousseau · Fontenay-le-Fleury, FR
Joost Schymkowitz · Meensel-Kiezegem, BE

Key dates

Filing date	May 28, 2014
Grant date	Jan 9, 2018
Priority date	—
Expiry date	May 28, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/42
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to the field of single-domain antibodies (also called nanobodies), more particularly single-domain antibodies against SOD1 protein isoforms. It also relates to the use of these nanobodies in medicine. Accordingly, methods to treat a disease using these nanobodies are provided herein. The single-domain antibodies are particularly envisaged for treatment of ALS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.